Scientists identify one cause of damage in Alzheimer's disease, find a way to stop it

November 9, 2010
Clear strands of toxic aggregated amyloid beta peptides, a hallmark of Alzheimer's disease, interact with proteins such as the anti-oxidant enzyme catalase, shown in red. The interaction disables catalase, resulting in oxidative damage to neural cells in culture. Protein-resistant coating (blue) on the aggregated amyloids inhibit these harmful interactions and protect of cells from amyloid beta-induced oxidative stress and toxicity. Credit: Christopher Burke for UC San Diego

Researchers suspect that a protein superstructure called amyloid beta is responsible for much of the neural damage of Alzheimer's disease.

A new study at the University of California, San Diego, shows that amyloid beta disrupts one of the brain's anti-oxidant proteins and demonstrates a way to protect that , and perhaps others, from amyloid's harmful effects.

"Amyloid seems to cause damage to cells," said chemistry professor Jerry Yang. "We have reported in a very detailed way one potential interaction of how amyloid can cause disease, and we found a way to stop it." His group's report of their results will appear in the in December.

Their study focused on catalase, an enzyme that mops up excess oxidants, because catalase normally helps to prevent the kind of damage seen in the brains of patients with and previous work had found catalase proteins deposited within .

Lila Habib, a bioengineering graduate student and the first author of the report, added amyloid to cultured neural cells and looked at its effects.

"We were able to determine that amyloid beta and this anti-oxidant enzyme, catalase, interact, and that this interaction harmed catalase so it wasn't able to perform its physiological function: to degrade hydrogen peroxide into oxygen and water," she said.

When Habib coated the amyloid with a small molecule designed to prevent its interaction with other proteins, she was able to restore the activity of catalase and return hydrogen peroxide to normal levels within the cells.

The coating Habib used to probe the interaction between amyloid and catalase is a candidate drug - one of a class of that Yang's lab has developed.

"Not only are we learning more about the disease, but we are also developing a potential strategy for treatment," said Yang, who is currently testing the new approach in a of the disease.

Explore further: Harmful amyloid interferes with trash pickup for cells in Alzheimer's disease

Related Stories

Anti-inflammatory drug blocks brain plaques

June 24, 2008

Brain destruction in Alzheimer's disease is caused by the build-up of a protein called amyloid beta in the brain, which triggers damaging inflammation and the destruction of nerve cells. Scientists had previously shown that ...

Amyloid beta protein gets bum rap

November 9, 2009

While too much amyloid beta protein in the brain is linked to the development of Alzheimer's disease, not enough of the protein in healthy brains can cause learning problems and forgetfulness, Saint Louis University scientists ...

Alzheimer's prevention role discovered for prions

July 3, 2007

A role for prion proteins, the much debated agents of mad cow disease and vCJD, has been identified. It appears that the normal prions produced by the body help to prevent the plaques that build up in the brain to cause Alzheimer’s ...

Researchers find new piece in Alzheimer's puzzle

February 25, 2009

Yale researchers have filled in a missing gap on the molecular road map of Alzheimer's disease. In the Feb. 26 issue of the journal Nature, the Yale team reports that cellular prion proteins trigger the process by which amyloid-beta ...

Recommended for you

Conch shells spill the secret to their toughness

May 26, 2017

The shells of marine organisms take a beating from impacts due to storms and tides, rocky shores, and sharp-toothed predators. But as recent research has demonstrated, one type of shell stands out above all the others in ...

Chemists synthesize molecular pretzels

May 26, 2017

Chemists at the University of Amsterdam's Van 't Hoff Institute for Molecular Sciences have discovered a new class of molecules. This week they report in Nature Communications on their synthesis method leading to 'quasi[1]catenanes': ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.